Immune response to trauma and fear
Part of Mental health clinical trials.
This study looks at how the body's immune and stress systems work together in people who have experienced trauma, by giving a harmless vaccine to temporarily boost inflammation. It may help explain why some people develop PTSD and others don't, which could lead to better treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have been through a traumatic event, such as an accident, assault, or natural disaster.
- You either currently have PTSD or have never been diagnosed with PTSD.
- You have no conditions that cause widespread inflammation, like rheumatoid arthritis or inflammatory bowel disease.
- You are not pregnant and do not plan to become pregnant in the next three months.
- You have no known allergies or bad reactions to the typhoid vaccine.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at why some teenagers develop post-traumatic stress disorder (PTSD) after a scary or dangerous event. It explores the brain and body changes that may be linked to PTSD and could help improve future treatments.
This study looks at how people with current PTSD—or people without PTSD—respond to fear and avoiding things they might find threatening. It may help researchers understand these patterns and how they differ after trauma.
This study tests if injecting a sugar-water solution around neck nerves can help PTSD that hasn't improved with standard treatments. Half the participants get sugar-water, half get salt-water, and you'll be assigned to usual care for 3 months first.
This trial studies a specific talk-therapy approach (psychodynamic psychotherapy) for people with post-traumatic stress disorder (PTSD) who still have significant symptoms despite prior treatment. You may be able to join if your PTSD symptoms are in a moderate range and you can safely participate without urgent safety risks or certain other conditions.
This study tests a new medication, TSND-201, to see if it is safe and effective for people living with PTSD. It is for adults who have already tried at least one other treatment and are looking for a new option.
This study tests a new therapy for children with PTSD. It aims to help children aged 6-14 reduce trauma symptoms by teaching them skills to manage distressing memories and feelings.
Hear when a new Posttraumatic Stress Disorder (PTSD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.